Gritstone bio Presents Improvements to EDGE™ Platform at AACR 2024
-- State-of-the-art neoantigen prediction platform now predicts HLA Class I presentation of epitopes with
Source: marketscreener.com
Stay updated with breaking news from Epitope Discovery. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
-- State-of-the-art neoantigen prediction platform now predicts HLA Class I presentation of epitopes with
-- Robust enrollment in Phase 2 portion of randomized Phase 2/3 study of GRANITE to date; 71 of 80 patients enrolled as of May 10, 2023 -- -- Gritstone prioritizing GRANITE; expanding Phase 2 from... | May 11, 2023
PEPperPRINT GmbH products, product reviews and application articles on SelectScience.